Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

486
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
486

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

B Cell Receptor's function in virus entry: Anti-SARS-CoV-2 B cell receptors can mediate viral entry in an ACE2-independent mechanism.

PLoS pathogens·2026
Same author

Phosphatidylserine receptors TIM-1 and AXL mediate tick-borne Powassan virus entry.

iScience·2025
Same author

Differential tropisms of old and new world hantaviruses influence virulence and developing host-directed antiviral candidates.

PLoS pathogens·2025
Same author

Drug screen reveals new potent host-targeted antivirals against Mpox virus.

Research square·2025
Same author

Drug screen reveals new potent host-targeted antivirals against Mpox virus.

bioRxiv : the preprint server for biology·2025
Same author

Optimization of a micro-scale air-liquid-interface model of human proximal airway epithelium for moderate throughput drug screening for SARS-CoV-2.

Respiratory research·2025

相关实验视频

Updated: Jun 9, 2025

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

702

开发使用NKG2A敲除人类多能干细胞衍生NK细胞的增强免疫疗法.

Yue Qin1, Qi Cui1, Guihua Sun1

  • 1Department of Neurodegenerative Diseases, Beckman Research Institute of City of Hope, 1500 E. Duarte Rd., Duarte, CA 91010, USA.

Cell reports
|October 24, 2024
PubMed
概括

通过将NKG2A免疫检查点敲除,对自然杀手 (NK) 细胞进行基因改造,可以显著提高它们对抗癌症和病毒感染的能力. 这些增强的NK细胞在临床前模型中显示出强大的抗瘤作用.

关键词:
CP: 免疫学 免疫学欧洲社会委员会 (ESCs) 是一个欧洲社会委员会.在GBMGBMGBMGBMGBM在 NK 细胞中,NK 细胞是 NK 细胞.在NKG2A中,NKG2A是NKG2A.公共服务中心 (PSCs) 的服务.癌症免疫疗法免疫疗法胚胎干细胞是一种胚胎干细胞.质母细胞瘤是什么这些是iPSCs.免疫检查点是一个检查点.免疫疗法 免疫疗法诱导多能干细胞的诱导干细胞.这种白血病是白血病.多能干细胞是一种多能干细胞.

更多相关视频

Generation of Natural Killer Cells from Human Expanded Potential Stem Cells
06:53

Generation of Natural Killer Cells from Human Expanded Potential Stem Cells

Published on: January 13, 2023

3.0K
Development, Expansion, and In vivo Monitoring of Human NK Cells from Human Embryonic Stem Cells hESCs and Induced Pluripotent Stem Cells iPSCs
09:02

Development, Expansion, and In vivo Monitoring of Human NK Cells from Human Embryonic Stem Cells hESCs and Induced Pluripotent Stem Cells iPSCs

Published on: April 23, 2013

16.8K

相关实验视频

Last Updated: Jun 9, 2025

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

702
Generation of Natural Killer Cells from Human Expanded Potential Stem Cells
06:53

Generation of Natural Killer Cells from Human Expanded Potential Stem Cells

Published on: January 13, 2023

3.0K
Development, Expansion, and In vivo Monitoring of Human NK Cells from Human Embryonic Stem Cells hESCs and Induced Pluripotent Stem Cells iPSCs
09:02

Development, Expansion, and In vivo Monitoring of Human NK Cells from Human Embryonic Stem Cells hESCs and Induced Pluripotent Stem Cells iPSCs

Published on: April 23, 2013

16.8K

科学领域:

  • 免疫学 免疫学 免疫学
  • 细胞疗法细胞疗法
  • 癌症研究 癌症研究

背景情况:

  • 癌症免疫疗法面临挑战,因为癌细胞利用免疫检查点逃避治疗.
  • 自然杀手 (NK) 细胞对于对瘤和病毒的天生的免疫力至关重要.
  • NKG2A是一种抑制性免疫检查点受体,表达在NK细胞上.

研究的目的:

  • 研究基因工程人类多能干细胞衍生NK (PSC-NK) 细胞缺乏NKG2A的治疗潜力.
  • 评估NKG2A-Knockout (KO) PSC-NK细胞增强的抗瘤和抗病毒功能.

主要方法:

  • 在人类多能干细胞 (hPSC) 中,NKG2A被淘汰.
  • hPSCs被分化为NK (PSC-NK) 细胞.
  • 进行了体外和体内测试,以评估对癌细胞和病毒感染细胞的细胞毒性,以及在质母细胞瘤小鼠模型中的抗瘤疗效.

主要成果:

  • NKG2A淘汰赛显著增强了PSC-NK细胞对HLA-E表达性质母细胞瘤 (GBM) 和白血病细胞的细胞毒性.
  • 在实验室中,NKG2A KO PSC-NK 细胞对 SARS-CoV-2 感染细胞的疗效增加.
  • 在体内研究显示强烈的抗瘤活性,抑制瘤进展和延长生存时间在GBM异种移植小鼠模型.

结论:

  • 在PSC-NK细胞中NKG2A淘汰代表了增强基于细胞的癌症免疫治疗的有希望的策略.
  • 基因工程PSC-NK细胞提供了随时可用的"现成"免疫疗法的潜在来源,由于它们的无限供应和易于基因修饰.